Description |
p-Hydroxycinnamic acid, a common dietary phenol, could inhibit platelet activity, with IC50s of 371 μM, 126 μM for thromboxane B2 production and lipopolysaccharide-induced prostaglandin E2 generation, respectively.
|
Target |
PGE2:126 μM (IC50)
TXB2:371 μM (IC50)
Human Endogenous Metabolite
|
In Vitro |
p-Hydroxycinnamic acid (p-Coumaric acid), is a ubiquitous plant metabolite with antioxidant and anti-inflammatory properties. p-Hydroxycinnamic acid (500 μM and 1 mM) reduces ADP-induced platelet aggregation (55•2 (SE 4•01) % and 35•6 (SE 2•35) % relative to basal level, respectively). p-Hydroxycinnamic acid is able to modify platelet function, a shear-inducing device that simulates primary haemostasis. p-Hydroxycinnamic acid interferes also with arachidonic acid cascade, reducing thromboxane B2 production and lipopolysaccharide-induced prostaglandin E2 generation (IC50 371 and 126 μM, respectively)[1].
|
Density | 1.3±0.1 g/cm3 |
Boiling Point | 346.1±17.0 °C at 760 mmHg |
Flash Point | 177.3±17.4 °C |
Exact Mass | 164.047348 |
PSA | 57.53000 |
LogP | 1.88 |
Vapour Pressure | 0.0±0.8 mmHg at 25°C |
Storage condition | -20°C |